secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001613103-22-000006
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic Q3 FY2022 revenue flat at $7.8B; GAAP EPS $1.10 (+17%), non-GAAP EPS $1.37 (+6%)
--------------------------------------------------------------------------------

- Revenue $7.763B flat YoY; organic growth 2%; COVID-19 impact on U.S. procedure volumes.
- GAAP diluted EPS $1.10 (+17%); non-GAAP diluted EPS $1.37 (+6%), a penny above consensus.
- Q4 guidance: organic revenue growth ~5.5%; non-GAAP EPS $1.56-$1.58.
- Diabetes segment revenue down 7% as reported (-5% organic) driven by U.S. declines.
- Cardiovascular up 3% organic; Medical Surgical up 1% organic; Neuroscience up 2% organic.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310322000006/0001613103-22-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310322000006/mdt-20220222.htm
  HTML page:      https://secwatch.observer/filing/0001613103-22-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer